CHOP Study Shows Chemotherapy-Resistant Neuroblastoma Cells Have More Active Inflammatory Sensing and Signaling
Published on
CHOP researchers have found that chemo-resistant mesenchymal cells in neuroblastoma might be vulnerable to immunotherapy.
Published on
CHOP researchers have found that chemo-resistant mesenchymal cells in neuroblastoma might be vulnerable to immunotherapy.
Published on
The award from March of Dimes recognizes Dr. Flake’s work, which has advanced the science that underlies our understanding of pregnancy, birth, and prenatal development.
Published on
A new study in Nature has documented the longest persistence of CAR T cell therapy to date.
Published on
The method could eventually lead to more personalized medicine approaches as well as properly diagnose patients with multiple disorders.
Published on
Method measures motor imitation skills, which have been challenging to measure consistently and precisely.
Published on
CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.
Published on
The Middleman Family Pavilion, including 24/7 Emergency Department, will give more families easier access to CHOP’s best-in-class pediatric specialists.
Published on
New test analyzes mitochondrial DNA to find and quantify certain variations and deletions, providing a useful diagnostic tool that helps guide treatment.
Published on
As part of a longstanding partnership with the United Arab Emirates (UAE) Emirates Health Services (EHS), Children’s Hospital of Philadelphia (CHOP)will exhibit leading medical breakthroughs in the EHS booth at the annual Arab Health Exhibition and Congress, which is taking place at the Dubai International Convention and Exhibition Centre this week.
Published on
The Asmund Laerdal Foundation and RQI Partners LLC’s Philanthropic Support Will Advance Best Pediatric Cardiac Arrest Prevention, Preparation, Education, and Resuscitation Practices.